Biogen Loses BAIT SHOP Status, Officially & Again (BIIB, PFE)
Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen had been under a corporate strategic review where it was evaluating strategic…